ADAR Investment Management’s Pfizer PFE Stock Holding History

ADAR Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$296K	Buy	+10,540	New	+$296K	7.9%	5

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ADAR Investment Management's PFE Position: Q3 2014 in Review

ADAR Investment Management opened a new position in Pfizer (PFE) in Q3 2014: 10,540 shares worth $296K. The stake represents 7.9% of the portfolio and ranks #5 among its holdings.

1,742 funds tracked by Wall St. Rank hold PFE as of Q3 2014.

ADAR Investment Management held 10,540 shares of Pfizer worth $296K as of Q3 2014.
Pfizer was a new ADAR Investment Management position in Q3 2014.
Pfizer made up 7.9% of ADAR Investment Management's portfolio in Q3 2014, its #5 holding.
1,742 funds tracked by Wall St. Rank held Pfizer as of Q3 2014.

Based on ADAR Investment Management's 13F filing for Q3 2014, filed 12 Nov 2014.